Menopausal hormone therapy and menopausal symptoms
- PMID: 24613533
- DOI: 10.1016/j.fertnstert.2014.02.032
Menopausal hormone therapy and menopausal symptoms
Abstract
A majority of women will experience bothersome symptoms related to declining and/or fluctuating levels of estrogen during their menopausal transition. Vasomotor symptoms, vaginal dryness, poor sleep, and depressed mood have all been found to worsen during the menopausal transition. While vasomotor symptoms gradually improve after menopause, the time course can be many years. Vaginal dryness does not improve without treatment, while the long-term course of sleep and mood deterioration is not clearly defined at this time. A small minority of women have vasomotor symptoms that persist throughout the remainder of their lives. These common menopausal symptoms all improve with estrogen treatment. Over the last 10 years, we have witnessed a dramatic reduction in enthusiasm for menopausal hormone therapy, despite its high efficacy relative to other treatments. We have also seen the emergence of sound, evidence-based clinical trials of non-hormonal alternatives that can control the common menopausal symptoms. Understanding the natural history of menopausal symptoms, and the risks and benefits of both hormonal and non-hormonal alternatives, helps the clinician individualize management plans to improve quality of life.
Keywords: Menopause; hormone therapy; vasomotor symptoms; vulvovaginal atrophy.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum.Fertil Steril. 2014 Apr;101(4):887-97. doi: 10.1016/j.fertnstert.2014.02.042. Fertil Steril. 2014. PMID: 24680648 Review.
-
Approach to the patient with menopausal symptoms.J Clin Endocrinol Metab. 2008 Dec;93(12):4567-75. doi: 10.1210/jc.2008-1272. J Clin Endocrinol Metab. 2008. PMID: 19056840
-
Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.Obstet Gynecol. 2013 Jan;121(1):172-6. doi: 10.1097/aog.0b013e31827a08c8. Obstet Gynecol. 2013. PMID: 23262943 Free PMC article.
-
NIH State-of-the-Science Conference Statement on management of menopause-related symptoms.NIH Consens State Sci Statements. 2005 Mar 21-23;22(1):1-38. NIH Consens State Sci Statements. 2005. PMID: 17308548 Review.
-
Modeling women's health during the menopausal transition: a longitudinal analysis.Menopause. 2007 Jan-Feb;14(1):53-62. doi: 10.1097/01.gme.0000229574.67376.ba. Menopause. 2007. PMID: 17023873
Cited by
-
An analysis of the influence of selected genetic and hormonal factors on the occurrence of depressive symptoms in late-reproductive-age women.Int J Environ Res Public Health. 2015 Mar 27;12(4):3547-63. doi: 10.3390/ijerph120403547. Int J Environ Res Public Health. 2015. PMID: 25826396 Free PMC article.
-
Analysis of the long-term beneficial effects of menopausal hormone therapy on sleep quality and menopausal symptoms.Exp Ther Med. 2019 Nov;18(5):3905-3912. doi: 10.3892/etm.2019.8058. Epub 2019 Sep 27. Exp Ther Med. 2019. PMID: 31656539 Free PMC article.
-
Effect of Soy Isoflavone on Hot Flushes, Endometrial Thickness, and Breast Clinical as well as Sonographic Features.Iran J Public Health. 2018 Mar;47(3):382-389. Iran J Public Health. 2018. PMID: 29845026 Free PMC article.
-
Identification of Steroidogenic Components Derived From Gardenia jasminoides Ellis Potentially Useful for Treating Postmenopausal Syndrome.Front Pharmacol. 2018 May 30;9:390. doi: 10.3389/fphar.2018.00390. eCollection 2018. Front Pharmacol. 2018. PMID: 29899696 Free PMC article.
-
Contributing factors for menopausal symptoms after surgical staging for endometrial cancer.Menopause. 2016 May;23(5):535-43. doi: 10.1097/GME.0000000000000576. Menopause. 2016. PMID: 26757269 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
